VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+54.39%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$2.24B
AUM Growth
+$2.24B
(+30%)
Cap. Flow
-$59.8M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
66.48%
Holding
69
New
5
Increased
8
Reduced
20
Closed
10
Top Buys
| 1 |
Tarsus Pharmaceuticals
TARS
|
$134M |
| 2 |
Aligos Therapeutics
ALGS
|
$98.1M |
| 3 |
Olema Pharmaceuticals
OLMA
|
$59.6M |
| 4 |
Curis
CRIS
|
$11.5M |
| 5 |
10x Genomics
TXG
|
$8.35M |
Top Sells
| 1 |
Immunovant
IMVT
|
$32.1M |
| 2 |
Rocket Pharmaceuticals
RCKT
|
$30.2M |
| 3 |
Arrowhead Research
ARWR
|
$28.5M |
| 4 |
Codexis
CDXS
|
$23.8M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$21.6M |
Sector Composition
| 1 | Healthcare | 90.89% |
| 2 | Financials | 5.49% |
| 3 | Materials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
26
DELISTED
Zogenix, Inc.
ZGNX
| $20.1M | 0.9% |
1,006,494
+188,559
| +23% | +$3.77M |
|
|
KDNY
27
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $19.1M | 0.85% |
1,206,266
-3,912,294
| -76% | +$2.9M |
|
28
Novavax
NVAX
$1.2B
| $17.6M | 0.78% |
157,487
-6,712
| -4% | -$748K |
|
29
Kura Oncology
KURA
$732M
| $17.2M | 0.77% |
525,262
-524,738
| -50% | -$17.1M |
|
30
Larimar Therapeutics
LRMR
$337M
| $17.1M | 0.76% |
799,662
| – | – |
|
|
31
Rocket Pharmaceuticals
RCKT
$358M
| $17M | 0.76% |
310,584
-550,064
| -64% | -$30.2M |
|
32
Akero Therapeutics
AKRO
$3.65B
| $16.3M | 0.73% |
633,426
+61,593
| +11% | +$1.59M |
|
|
33
Immunovant
IMVT
$2.91B
| $16.1M | 0.72% |
347,662
-694,798
| -67% | -$32.1M |
|
|
34
Arrowhead Research
ARWR
$3.84B
| $15.7M | 0.7% |
205,091
-371,414
| -64% | -$28.5M |
|
|
MREO
35
Mereo BioPharma
MREO
$275M
| $15.1M | 0.67% |
4,220,938
-2,000,000
| -32% | -$7.16M |
|
36
Cytokinetics
CYTK
$5.98B
| $14.5M | 0.65% |
700,000
| – | – |
|
37
Zymeworks
ZYME
$1.07B
| $13.5M | 0.6% |
286,064
-354,347
| -55% | -$16.7M |
|
|
38
Curis
CRIS
$21.5M
| $11.5M | 0.51% |
+1,400,000
| New | +$11.5M |
|
39
Aclaris Therapeutics
ACRS
$223M
| $10.7M | 0.48% |
1,647,214
| – | – |
|
|
CALT
40
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $10.5M | 0.47% |
311,030
-268,970
| -46% | -$9.04M |
|
|
PSTX
41
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $10.2M | 0.45% |
926,447
-2
| -0% | -$22 |
|
42
Q32 Bio
QTTB
$20.9M
| $9.63M | 0.43% |
853,143
| – | – |
|
43
Matinas BioPharma
MTNB
$10.1M
| $8.77M | 0.39% |
6,451,612
-4,827,711
| -43% | -$6.57M |
|
|
44
Codexis
CDXS
$218M
| $8.47M | 0.38% |
388,144
-1,088,145
| -74% | -$23.8M |
|
|
45
10x Genomics
TXG
$1.66B
| $8.35M | 0.37% |
+58,977
| New | +$8.35M |
|
46
Aurinia Pharmaceuticals
AUPH
$1.58B
| $6.93M | 0.31% |
500,732
| – | – |
|
47
Dyne Therapeutics
DYN
$1.92B
| $6.62M | 0.3% |
315,000
| – | – |
|
|
ORTX
48
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $5.73M | 0.26% |
1,325,736
| – | – |
|
49
KALA BIO
KALA
$105M
| $5.34M | 0.24% |
786,883
| – | – |
|
|
CNST
50
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $4.04M | 0.18% |
140,298
| – | – |
|